Iris freckle: a distinct entity
British Journal of Ophthalmology · 2024
DOI: 10.1136/bjo-2023-325009 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Yağmur Seda Yeşiltaş und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmic Oncology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Microscopy, Acoustic, Iris Neoplasms, Nevus, Pigmented. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Research to Prevent Blindness.
Abstract (Originalsprache)
Purpose
To report distinctive clinical and imaging features of iris freckles to differentiate them from iris nevi.
Design
Retrospective observational study. Subjects 53 patients (277 freckles) with incidental iris freckles and 102 patients (104 nevi) with iris nevi that are either clinically stable or pathologically confirmed.
Methods
Patient data were collected from the Department of Ophthalmic Oncology, Cleveland Clinic, Cole Eye Institute database (2012–2023). Lesion characteristics were recorded from slit-lamp examination descriptions and review of colour photographs. Ancillary imaging features observed using anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) were assessed in patients (where available). Main outcome measures Comparison of clinical and imaging features of iris freckles and iris nevi.
Results
A total of 277 iris freckles and 104 iris nevi were analysed. Iris freckles were more frequently bilateral (17%; nevi 0%) and multiple (69%; nevi 2%) and located centrally (89%; nevi 17%) compared with iris nevi (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmic Oncology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, USA.
- Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, USA.
- Department of Ophthalmology, Hoag Memorial Presbyterian Hospital, Irvine, California, USA.
- Department of Ophthalmology, Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, USA.
- Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Ophthalmic Oncology, Cleveland Clinic Cole Eye Institute, Cleveland, Ohio, USA singha@ccf.org.
ORCID-Profile: Yağmur Seda Yeşiltaş, Arun D Singh
Förderung
- Research to Prevent Blindness
Zitieren
APA
Yeşiltaş, Y. S., Zhou, M., Zabor, E. C., Oakey, Z., Singh, N., Sedaghat, A., Yeaney, G., & Singh, A. D. (2024). Iris freckle: a distinct entity. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2023-325009
Vancouver
Yeşiltaş YS, Zhou M, Zabor EC, Oakey Z, Singh N, Sedaghat A, et al. Iris freckle: a distinct entity. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2023-325009
BibTeX
@article{Yeilta2024,
author = {Yeşiltaş, Yağmur Seda and Zhou, Millennia and Zabor, Emily C and Oakey, Zackery and Singh, Nakul and Sedaghat, Ahad and Yeaney, Gabrielle and Singh, Arun D},
title = {Iris freckle: a distinct entity},
journal = {British Journal of Ophthalmology},
year = {2024},
doi = {10.1136/bjo-2023-325009}
}
EUVIMED